radiation therapy

Research in Review

PRRT Use Supported by More than 10 Years of Evidence

10/18/2016

JCP Editors

A review of more than 10 years of published clinical data supports the use of peptide receptor radionuclide therapy (PRRT)-containing regimens as a way of improving outcomes, minimizing toxicity, and reducing the...

A...

10/18/2016

Journal of Clinical Pathways

Quiz

Friday Morning Quiz: Week of October 2-8

10/06/2016

JCP Editors

In the first study to evaluate patient-reported outcomes from the NRG Oncology/RTOG 0415 trial, researchers found that which form of radiation therapy offers similar health-related quality of life outcomes in...

In the...

10/06/2016

Journal of Clinical Pathways

Department

Hypofractionated Radiation Therapy Offers Value-Based Care for Patients With Prostate Cancer

10/04/2016

JCP Editors

In the first study to evaluate patient-reported outcomes from the NRG Oncology/RTOG 0415 trial, treatment with hypofractionated radiation therapy offers similar health-related quality of life (HRQoL) outcomes in...

In the...

10/04/2016

Journal of Clinical Pathways

Department

Hypofractionated Radiation Therapy Safer, Halves Treatment Time in NSCLC

09/27/2016

JCP Editors

Hypofractionated radiation therapy is less toxic and just as effective as conventional radiation therapy in patients with non-small cell lung cancer (NSCLC), according to research presented at the 58th Annual Meeting...

...

09/27/2016

Journal of Clinical Pathways

Quiz

Friday Morning Quiz: Week of September 18-24

09/22/2016

JCP Editors

A study published in the New England Journal of Medicine showed that localized prostate cancer is more likely to metastasize if patients receive which of the following treatments? radiation therapy active...

A...

09/22/2016

Journal of Clinical Pathways

Research in Review

Prostate Cancer Metastasis More Common Among Patients Receiving Active Surveillance

09/21/2016

JCP Editors

While survival at 10 years is similar, localized prostate cancer may be more likely to metastasize in men receiving active surveillance compared with those who have surgery or radiation therapy, according to results...

While...

09/21/2016

Journal of Clinical Pathways

Research in Review

Factors Associated With Early Death Among Elderly Patients With Lymphoma

09/14/2016

JCP Editors

Administrative and cancer registry data, routinely integrated within modern electronic medical records, can help determine which patients with lymphoma are at the highest risk of dying from chemotherapy, according to...

...

09/14/2016

Journal of Clinical Pathways

Research in Review

Immunotherapy Plus Chemotherapy Kills More Cancer Cells Than Chemotherapy Alone

09/09/2016

JCP Editors

When chemotherapy alone is used to treat cancer, some dormant cells may survive and become resistant to additional treatment; but, when combined with immunotherapy, the majority of these cells may be destroyed,...

When...

09/09/2016

Journal of Clinical Pathways

Research in Review

Little Survival Benefit from WBRT in NSCLC Patients With Brain Metastasis

09/08/2016

JCP Editors

Patients with non-small cell lung cancer and brain metastasis can be spared whole brain radiotherapy (WBRT), as it does little or has no effect on survival and quality of life, according to a study published in The...

...

09/08/2016

Journal of Clinical Pathways

Research in Review

Noncompliance With NCCN Guidelines Can Worsen Rectal Cancer Survival

08/31/2016

JCP Editors

Not complying with recommendations found in National Comprehensive Cancer Network (NCCN) guidelines for locally advanced rectal cancer may led to worse overall survival, according to a study published in the journal...

Not...

08/31/2016

Journal of Clinical Pathways